Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026)
Tectonic Therapeutic (TECX) reported Free Cash Flow of -$18.4 million for Q1 2026, down 40.59% year-over-year from -$31.0 million in Q1 2025, and down 27.46% quarter-over-quarter from -$14.5 million in Q4 2025.
Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Free Cash Flow data on file, last reported at -$18.4 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$18.4 million, down 40.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$65.6 million (down 4.03% YoY), and the FY2025 annual result was -$60.3 million, down 1.77% from the prior year.
- Free Cash Flow fell to -$18.4 million in Q1 2026 per TECX's latest filing, from -$14.5 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$473000.0 in Q2 2023 and troughed at -$29.2 million in Q2 2022.
- A 5-year average of -$16.3 million and a median of -$16.2 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow surged 98.38% in 2023, then plunged 2728.33% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$23.9 million in 2022, then jumped by 51.1% to -$11.7 million in 2023, then slumped by 43.71% to -$16.8 million in 2024, then climbed by 14.05% to -$14.5 million in 2025, then declined by 27.46% to -$18.4 million in 2026.
- Business Quant data shows TECX's Free Cash Flow at -$18.4 million in Q1 2026, -$14.5 million in Q4 2025, and -$18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 63,220.27 |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -18.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.43 Mn |
| Mar 31, 2026 | -18.43 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Mar 31, 2024 | -9.28 Mn |
| Mar 31, 2024 | -9.28 Mn |
| Dec 31, 2023 | -11.71 Mn |
| Dec 31, 2023 | -11.71 Mn |